Answer:
Phase III
Explanation:
The given condition fall in the trial phase (Phase III) of cinical study which aims to:
- Determine drug's effectiveness (primary goal)
- Determine long-term drug safety
- Confirm findings
In Phase III, randomised, double-blind, placebo-controlled, parallel group study is majorly to evaluate the efficacy and safety of placebo in episodic migraine prevention in children (6 to < 12 years of age) and adolescents (12 to < 18 years of age).
The trial consists of four phases: screening; double-blind therapy period for 24 weeks in which placebo or Erenumab is given to subject as dose 1, dose 2 or dose 3 (based on the participant's body weight) once a month via subcutaneous injection; optional dose level blinded extension phase (40 weeks) which involves subjects recieve dose1, 2 and 3 of placebo, and at last it follows a safety follow-up phase for 12 weeks (after 16 weeks of the last dose of investigational drug).
Hence, the clinical phase is phase III.
Answer: Baseball
Hope this helps!^^
Answer:
Jimmy's blood type: "O" Blood
Jimmy can receive blood from: O blood type only.
Explanation:
The anti-A antibodies are present in the plasma of "B" blood type. Similarly, the blood type "A" has anti-B antibodies in its plasma. Since Jimmy's blood is showing agglutination with both "A" and "B" blood type, he has "O" blood type.
The "O" blood type has both anti-A and anti-B antibodies in its plasma and exhibits agglutination with both A and B blood type. The "A" antigen of "A" blood type reacts with anti A antibodies of jimmy's blood while "B" antigen of "B" blood type would exhibit agglutination with "anti B antibodies" of Jimmy's blood. He can get blood from "O" blood type only as he has both anti-A and anti B antibodies in his blood plasma.
I think they're set in a vertical motion. Up to the crest and down towards the trough. Something about kinetic energy
